Oslo University Hospital, Aker is one of the four main campuses of Oslo University Hospital. It was an independent hospital from 1895 to 2009, under the name Aker Hospital and from 2002 Aker University Hospital.

During the past decade, Oslo University Hospital conducted 478 clinical trials. In the 10-year time frame, 478 clinical trials started and 22 clinical trials were completed, i.e. on average, 4.6% percent of trials that started reached the finish line to date. In the past 5 years, 217 clinical trials started and 19 clinical trials were completed. i.e. 8.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oslo University Hospital" #1 sponsor was "Oslo University Hospital" with 403 trials, followed by "Ullevaal University Hospital" with 33 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 26 trials sponsored, "University of Oslo" with 13 trials sponsored and "Haukeland University Hospital" with 13 trials sponsored. Other sponsors include 288 different institutions and companies that sponsored additional 194 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oslo University Hospital" #1 collaborator was "Oslo University Hospital" with 71 trials as a collaborator, "University of Oslo" with 64 trials as a collaborator, "St. Olavs Hospital" with 53 trials as a collaborator, "Haukeland University Hospital" with 52 trials as a collaborator and "University Hospital of North Norway" with 43 trials as a collaborator. Other collaborators include 1265 different institutions and companies that were collaborators in the rest 621 trials.

According to Clinical.Site data, the most researched conditions in "Oslo University Hospital" are "Colorectal Cancer" (13 trials), "Prostate Cancer" (13 trials), "Cancer" (12 trials), "Pain" (12 trials) and "Breast Cancer" (10 trials). Many other conditions were trialed in "Oslo University Hospital" in a lesser frequency.

Most popular intervention types in "Oslo University Hospital" are "Drug" (283 trials), "Procedure" (133 trials), "Other" (132 trials), "Device" (86 trials) and "Behavioral" (48 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "carboplatin" (12 trials), "Atezolizumab" (9 trials), "doxorubicin hydrochloride" (9 trials) and "etoposide" (9 trials). Other intervention names were less common.

The vast majority of trials in "Oslo University Hospital" are 675 trials for "All" genders, 71 trials for "Female" genders and 34 trials for "Male" genders.

Currently, there are 302 active trials in "Oslo University Hospital". 3 are not yet recruiting, 178 are recruiting, 111 are Active, not recruiting, and 10 are Enrolling by invitation. In total, there were 357 completed trials in Oslo University Hospital, 3 suspended trials, and 32 terminated clinical trials to date.

Out of the total trials that were conducted in Oslo University Hospital, 61 "Phase 1" clinical trials were conducted, 155 "Phase 2" clinical trials and 102 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 53 trials, and there were also 256 trials that are defined as “Not Applicable".